Early Administration of PCSK9 Inhibitors After Thrombectomy for Atherosclerotic Acute Ischemic Stroke: A Randomized Controlled Trial

NCT07295366 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Acute Stroke

Interventions

DRUG: Elavolocumab(420 mg injections)

Sponsor

The Affiliated Hospital of Xuzhou Medical University